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Mutually exclusive cell fate determination of CD4 helper or CD8 killer T cells occurs in the thymus. These
T-cell subsets are not believed to redirect other lineages. Herewe showed that retinoic acid and transforming
growth factor-b1 promoted the differentiation of CD8aa T cells from CD4 T cells in a Runx3-dependent
manner. These cells were inferred to belong to immunoregulatory populations because subpopulations of
CD8aa1TCRab T cells are known to suppress activated T cells, and mice with Runx32/2 T cells showed
defects during recovery from experimental allergic encephalomyelitis. Our results demonstrate that CD4 T
cells play fundamental roles in controlling immune reactions through promotion and attenuation. We
accordingly anticipate that clarifying the mechanisms underlying this process will provide insights leading
to autoimmune and immunodeficiency disease therapies.
D
uring T cell maturation, T-cell receptor (TCR) ab-bearing cells express both CD4 and CD8 (double-
positive thymocytes) molecules on their surface. Transition from double to single positive (CD41CD82
or CD42CD81) requires the selection of TCRab with intrathymic ligands that are presented by major
histocompatibility complexes (MHCs). CD4 and CD8 coreceptors interact with MHC class II and I molecules,
respectively, thereby resulting in the interaction of TCRab with ligands/MHC complexes and stabilizing CD4 or
CD8 expression on maturing TCRab T cells. Simultaneously, thymocytes diverge into functionally distinct CD4
helper and CD8 killer cells1. A correlation between the mechanisms of antigen recognition and functional
divergence of T cells suggests that the commitment of these cells is irreversible. The redirection of CD4 T cells
to the CD8 lineage and vice versa is not believed to occur in the periphery.
Establishment of central and peripheral tolerance is important formaintaining immunological homeostasis. In
addition to naturally occurring CD41CD251Foxp31 regulatory T cells (nTregs), several phenotypically and
functionally distinct regulatory T-cell populations have been suggested2–6. To date, at least four CD81 Treg
subsets have been identified, and these include CD81CD282, CD81CD251, CD81CD1221, and CD8aa T
cells. Among them, two CD81 T-cell subsets exhibit a special property in suppressing activated, but not naı¨ve, T
cells7–9. CD8ab1CD1221CD441 inducible costimulator ligand (ICOSL)1 TCR ab1T cells attenuate immune
responses by inhibiting follicular T helper cell (TFH) via recognition of Qa-1, which is expressed on TFH cells in an
activation-dependent manner7. The CD8aa1CD1221TCRab1 T-cell subset was identified during the screen-
ing of Treg cells that inhibit experimental autoimmune encephalomyelitis (EAE) in mice10,11. This CD8aa T-cell
subset recognizes the pathogenic TCR-derived peptide that is present on the Qa-1 molecule of pathogenic T cells
in an activation-dependent manner and inhibits pathogenic T cells. In addition, an immunoregulatory role of
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CD8aaTCRab T cells inhibits colitis, induced by the adoptive trans-
fer of naı¨ve CD4 T cells into severe combined immunodeficient
(SCID) mice6. Second, non-obese diabetic (NOD) mice are defective
in the generation of CD8aaTCRab T cells, suggesting a regulatory
role of these cell populations12. In addition, genetic control elements,
which are required for clonal deviation to CD8aa T cells, also regu-
late rescue from clonal deletion of nTregs in the thymus13, suggesting
that these different subsets of immunoregulatory T cells share a
common thymic selection mechanism.
The developmental pathway of CD8aa1TCRab1 T cells is con-
troversial because of the following findings. First, the accumu-
lation of autoreactive TCRs was observed in the repertoire of
CD8aa1TCRab1 T cells14. Second, CD8aa1TCRab1 T cells
comprise only a small portion of T cells in the lymph node and spleen
(,1% of T cells) but a large portion (approximately 40% of T cells) in
the intraepithelium of the gut. For this reason it was previously
believed that CD8aa1TCRab1 T cells were of extrathymic origin
and differentiated locally in the gut; however, they are now consid-
ered to originate in the thymus15. In the thymus, CD8aa1TCRab1
precursor T cells were selected by high-affinity self-antigens, such as
nTregs12,16,17. The selected precursor T cells were CD4- and CD8-
double-negative cells. The final maturation of these cells, including
the expression of CD8aa, occurs in the gut18. Transforming growth
factor (TGF)-b1 plays a key role in the generation of nTregs and
CD8aa T cells during selection in the thymus19,20. Thus, the regula-
tory factors that control development of CD8aa1TCRab1 intest-
inal intraepithelial lymphocytes (IELs) and the molecular pathways
of this cell population have been elucidated. However, the origin of
CD8aa1TCRab1T cells outside intestines and the factors required
for their generation are incompletely understood.
In this study, we showed that immune reactions promote the
differentiation of CD8aa1TCRab1 T cells from naı¨ve CD4 T cells
within peripheral lymphoid tissues. Among the factors induced by
inflammation, TGF-b1, all-trans retinoic acid (atRA), and interleu-
kin (IL)-2 are indispensable for the differentiation of CD8aa T cells.
Striking similarities were observed between induced Tregs (iTregs)
and CD8aa T cells, with the same signals required for the differenti-
ation of iTregs. In addition, Runx3-deficient CD4 T cells have lost
their ability to become CD8aa T cells, indicating that Runx3 plays a
critical role in this differentiation. Furthermore, mice whose T cells
were Runx3-deficient showed defects in recovery from EAE. Thus
CD8aa Tregs were confirmed to be generated in the thymus and
periphery, like CD41Foxp31 Tregs, and the signals required for
CD8aa Tregs were the same as those required for CD41Foxp31
Tregs. We thus demonstrated that the newly identified Treg subset,
namely CD8aa Tregs that are derived from CD4 T cells, plays an
immunoregulatory role in EAE.
Results
Generation of CD8aa T cells in the spleen by immunization. In
addition to CD41CD251Foxp31 T cells21–23, several populations
have been identified as immunoregulatory cells7,10,24,25. CD8 Treg sub-
sets negatively regulate activated, but not naı¨ve, T cell functions7,10,24,25.
Among these cell subsets, CD8aaTCRab T cells have been re-
ported to play important roles in the gut mucosal immunity
and prevent autoimmune diseases6,12,13. However, the origin of
this subset and mechanisms of its development remain unclear.
The initial commitment of CD8aa T cells occurs in the thymus
following exposure to agonist self-peptides16–18, and their genera-
tion requires a TGF-b1 signal19. When positively selected CD8aa
TCRab precursor T cells reach the gut, they express CD8aa
molecules in an IL-15-dependent manner18. Importantly, the ex-
pression of CD8aa is induced on CD8ab T cells by immunization
and is required for the generation of memory CD8ab T cells26,27.
We accordingly examined the effect of immunization on the gene-
ration of CD8aa single-positive cells in the spleen. As anticipated,
immunization induced the generation of CD8aa single-positive
T cells (6.5% of CD42CD8ab2CD8aa1TCRb1 T cells within
CD42 T cells in immunized spleen compared with 2.5% in non-
immunized spleen; Fig. 1A).
Generation of CD8aa T cells from CD4TCRab T cells in Rag22/2
mice. With the aim of identifying the subsets that potentially
differentiate into CD8aa T cells, their generation was examined at
day 20 after naı¨ve CD4 and CD8ab T cells were adoptively
transferred into Rag22/2 mice. Whereas CD8aa T cells were not
found in either case after 20 days, in some Rag22/2 mice that
received naı¨ve CD4 T cells they were found after approximately 6
months. A few CD8aa-positive cells were found in all tissues
examined, with a significantly larger number observed in Peyer’s
patches (PPs; Fig. 1B). These observations indicate that naı¨ve CD4
T cells can differentiate into CD8aa T cells, at least under these
experimental conditions.
TGF-b1, atRA, and IL-2 promote differentiation ofCD8aaTCRab
Tregs from naı¨ve CD4 T cells in vitro. To investigate the me-
chanisms of differentiation from CD4 into CD8aa T cells, we first
focused on the factors required for the generation of iTregs or
CD41Foxp31 cells. We added the factors to a conventional in
vitro CD4 T-cell differentiation assay. IL-2, TGF-b1, and atRA
generated CD8aa T cells from CD4 T cells (Fig. 2A). Although
atRA played only a supporting role in the differentiation of iTreg
cells, the generation of CD8aa T cells depended on all three factors
(Fig. 2A and data not shown). To exclude the possibility that CD8aa
T cells were derived from contaminated CD8ab cells, CD8ab T cells
were cultured under the same conditions as those used for the
differentiation of CD8aa from CD4 T cells, and no CD8aa T cells
were observed (Fig. 2B). Moreover, CD8ab T cells have the ability to
inhibit CD4-derived CD8aa T cell differentiation, as shown in
Fig 2C. These observations indicate that CD4 T cells and not
CD8ab T cells are the major source of peripheral CD8aa T cells.
Because ILs play critical roles in the determination of helper T-cell
subsets, we further examined the effects of various ILs on the dif-
ferentiation of CD8aa. Our results showed that IL-2 exerted the
strongest effect on the generation of CD8aa T cells (Fig. 2D).
Antigen dose has been shown to affect the differentiation of
CD8aa T cells. In the thymus, a low concentration of an agonist
induces CD8ab T cells, whereas a high concentration induces
CD8aa T cells. atRA concentration influences the differentiation
of iTreg and Th17 cells28,29. Thus, antigen dose and atRA con-
centration influence various processes in cell fate determination.
We accordingly examined the effects of TCR signal strength and
atRA concentration on differentiation of CD8aa T cells. A high
percentage of CD8aa T cells was found after culture with strong
TCR stimulation and high atRA concentration (Fig. 2E).
Runx3-dependent generation of CD8aaTCRab Tregs in vitro.
With the aim of characteristizing CD8aa T cells (CD8a positive
fraction in Fig 3A or CD8aa cells in Fig 3B) that were generated in
vitro, their gene expression profile was compared with iTregs (CD8
negative fraction shown in Fig 3A or iTreg cells in Fig 3B) derived
from the same culture condition (as shown in Fig 3A) and previously
well-characterized CD8 TCRab Tregs7,9,24,30. The expression of
granzymes A and B increased in the CD8aa population, whereas
that of Foxp3 decreased (Fig. 3A, B). The expression of CD122 and
ICOSL on the surface was also specifically induced in CD8aa T cells
(Fig. 3A). The expression pattern of these genes was similar to that of
other CD8 Treg cells7,9,24,30. Recent studies have indicated that Runx3
is a major regulator of CD8ab T cells, while ThPOK is a major
regulator of CD4 T cells31–33. We accordingly examined the pos-
sibility that these factors were involved in the differentiation from
CD4 to CD8aa T cells. Runx1 and ThPOK were expressed speci-
fically in naı¨ve CD4 T cells (Fig. 3B). After the generation of CD8aa
www.nature.com/scientificreports
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T cells, only Runx3 expression was observed, while this was not
found in the iTreg subset (Fig. 3B). Of note, we had previously
found that Runx2 and Runx3 are required for TGF-b1 and atRA
signals in IgA class switching in B cells34,35. Thus, it was con-
ceivable that Runx3 contributed to the differentiation of CD8aa
cells. As anticipated, Runx32/2CD4 T cells were unable to dif-
ferentiate into CD8aa T cells (Fig. 4). These observations support
the hypothesis that CD4-derived CD8aa T cells function as
regulatory cells in vivo and that Runx3 is essential for the
generation of these lineage cells.
Generation of CD8aa Tregs from CD4 T cells in vivo requires
Runx3. To determine whether CD4 T cells differentiate into
CD8aa T cells in vivo, naı¨ve CD4 T cells from C57BL/6 (CD45.2)
Figure 1 | Generation of CD8aa T cells in Rag22/2mice. (A) Fluorescence-activated cell sorting (FACS) analysis of CD8aa1CD8ab2CD42TCRab T
cells in the spleen after immunization ofWT (C57BL/6) mice with NP-CGG/Alum. Horizontal axis indicate percentage of CD8aa T cells within CD42 T
cells. *p, 0.05; n5 3. TCR, T-cell receptor. (B) FACS analysis of lymphocytes fromRag22/2mice (CD45.1) that had received naı¨ve CD4T cells (CD45.2)
6 months previously. TCRab1CD45.21 cells were examined for CD4 and CD8a expression. CD42CD8a1 (I) and CD41CD8a1 (II) T cells were
further examined for CD8a and CD8b expression. IELs, intestinal intraepithelial lymphocytes, PP, Peyer’s patches. CD8aa T cell differentiations from
CD4 T cells in Rag22/2 mice were confirmed in two of four mice analyzed, and representative data are shown.
www.nature.com/scientificreports
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Figure 2 | TGF-b1, atRA, and IL-2 promote differentiation of CD8aaTCRab regulatory T cell (Treg) from naı¨ve CD4 T cells in vitro. (A) Naı¨ve CD41
T cells were stimulated with a-CD28, IL-2, TGF-b1, and atRA on a-CD3e-coated plates. CD8aa1CD42 T cells were analyzed by FACS. (B) CD8ab1 T
cells were stimulated under conditions mentioned in A. (C) Total spleen T cells (41% CD8ab1 T cells and 56% CD4 T cells) were stimulated under
conditions mentioned in A. (D) Naı¨ve CD41 T cells were cultured with various ILs and TGF-b11atRA. (E) Naı¨ve CD41 T cells were stimulated with
TGF-b1, IL-2, and various atRA concentrations on plates coated with indicated concentrations of a-CD3e. Cell differentiation was analyzed by FACS. All
experiments were performed at least thrice; representative data are shown.
www.nature.com/scientificreports
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mice were adoptively transferred into Rag22/2mice with a C57BL/6
background (CD45.1), and the generation of CD8aa T cells was
examined after atRA administration. Given that the homing loca-
tion of transferred CD4 T cells cannot be controlled, absolute cell
numbers of transferred T cells at PP, IEL, and LPL varied sub-
stantially. Accordingly, CD8aa T cell differentiation was examined
by assessing the percentages of CD8aa cells. CD8aaT cells appeared
in an atRA-dependent manner in all tissues examined (Fig. 5). The
percentage of CD8aa T cells was significantly higher in PPs and IELs
than that in controls (12.2% of CD8aa1CD42TCRab1 T cells in
atRA-treated PPs compared with 0.05% in controls; 10.0% in the
atRA-treated sIEL compared with 0.09% in controls; Fig. 5). These
results indicate that the atRA-dependent differentiation of CD4 T
cells into CD8aa T cells occurred in vivo. To exclude the possibility
that CD8aa T cells were derived from contaminated CD8ab T cells,
we assessed the influence of CD8ab T cells on the generation of
Figure 3 | Gene expressions of CD8aaTCRab Tregs differentiated in vitro. (A) Naı¨ve CD41 T cells were stimulated under conditions mentioned in
Fig. 2(A). Gene expression was estimated by FACS. (B) Naı¨ve CD41 T cells were stimulated under conditions mentioned in Fig. 2(A). iTreg (CD41T)
and CD8aa T (CD81 T) cells were sorted from the cultured cells (shown in Fig 3A), and gene expression was analyzed by reverse transcription–
polymerase chain reaction. Naı¨ve CD4 T cells (CD41 CD62L1 T cells), CD8ab T cells were used for control. Naive CD4, CD8ab, iTreg, and CD8aa
indicate RNA source used for cDNA generation. Fivefold serial dilutions of cDNAs were amplified for the transcripts indicated. All experiments were
performed at least thrice, and representative data are shown.
Figure 4 | Differentiation of CD8aa Tregs fromCD4 T cells requires Runx3. Naı¨ve CD4 T cells fromwild type (WT) or Runx32/2FL-derived cells were
stimulated under the conditions mentioned in Fig. 2(A). CD8aa1CD42 T cells were analyzed by FACS. All experiments were performed thrice;
representative data are shown.
www.nature.com/scientificreports
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CD8aa T cells by modulating the ratio of CD8ab T cells within naı¨ve
CD4 T donor cells. Naı¨ve CD4 T cells used for a series of cell transfer
experiments contained fewer than 0.02% CD8ab T cells. Purified
naı¨ve CD4 T cells were transferred into Rag22/2 mice with or
without CD8ab T cells, and the generation of CD8aa T cells in
vivo was assessed. There was negligible difference in the percentage
of CD8aa T cells between mice carrying CD4 T cell populations
containing 0.02% CD8ab T cells and those carrying populations con-
taining 0.12%CD8ab T cells (data not shown). In addition, naı¨ve CD4
T cells, contaminated less than 0.002% by CD8ab T cells, differen-
tiated as efficiently as CD4 T cell populations carrying 0.02% CD8ab
T cells in Rag22/2mice. These results indicate that CD8ab T cells are
not the major source of CD8aa T cells differentiated in vivo.
The contribution of Runx3 to differentiation of CD4-CD8aa in
vivowas further determined using Runx3-deficient naı¨ve CD4T cells
as donor. No CD8aa T cells were observed in either atRA-treated or
non treatedmice (Fig. 5). However, the preferential differentiation of
CD8ab1 T cells, but not CD8aa1 T cells, was observed following
treatment with atRA in high doses (Supplementary Fig. S1).
Considering all results, Runx3 plays a special role in the differenti-
ation of CD8aa T cells from CD4 T cells in vivo. In addition, several
other signals that were not examined in this study contribute to CD8
T cell generation from CD4 T cells in vivo; Runx32/2 naı¨ve CD4 T
cells cannot differentiate CD8a1 T cells in vitro. In view of the
functional redundancy of Runx family transcription factors, their
contribution to the differentiation of CD4 T cells into CD8 T cells
was investigated using Runx22/2Runx32/2CD4 T cells. Admini-
stration of high-dose atRA could not rescue the defect in the genera-
tion of CD8 T cells (data not shown), indicating that Runx2 and
Runx3 play critical roles in the differentiation of CD4 T cells into
Figure 5 | Generation of CD8aa Tregs from CD4 T cells in vivo requires Runx3. FACS analysis of lymphocytes from Rag22/2 mice (CD45.1) that
received naı¨ve CD4 T cells (CD45.2) fromWT or Runx32/2 FL-derived cells after atRA administration. TCRab1CD45.21 cells were examined for CD4
and CD8a expression (all samples). CD4-CD8a1 T cells were further examined for CD8a and CD8b expression in case of atRA-administrated samples.
All experiments were performed at least thrice; representative data are shown. LPLs, lamina propria lymphocytes.
www.nature.com/scientificreports
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CD8 T cells. However, the precise roles of each Runx factor in the
differentiation into various CD4-derived CD8 T cell subsets remain
to be investigated.
CD4 T cells differentiate into CD8aa Tregs during immune
response and attenuate immune reactions. Accumulating evi-
dence indicates that the gut is rich in atRA28,29,36,37, and RA-
dependent events are believed to occur preferentially in the gut.
However, the spontaneous differentiation of CD4 T cells into
CD8aa T cells was not observed in the gut in the absence of atRA
administration (Fig. 5). The physiological relevance of differentiation
of CD4 T cells into CD8aa T cells in normal immunological
reactions is thus debatable. Recent reports have demonstrated that
RA is required to promote the effector responses of CD4 T cells and
is more abundant in inflamed tissues than in the gut38,39. We
accordingly investigated whether the differentiation of CD4 T cells
into CD8aa T cells can be induced by immunization. Generation of
CD8aa T cells in Rag22/2 mice that received naı¨ve CD4 T cells was
assessed after immunization. On days 1, 3, and 6 after immunization,
approximately 1% of CD8aa T cells were observed in the spleen
(Fig. 6A). This value was not very different from that observed
after usual immunization. Approximately 2%–3% of the cells were
CD8aa1 within TCRab1CD8ab2 T cells (Figure 1A and data not
shown). Significantly larger populations of CD8aa1 T cells were
observed in PPs, IELs, and lamina propria lymphocytes on day 6
(Fig. 6B). In contrast, hardly any CD8aa1 T cells were observed
in the gut on day 3 (Fig. 6B). Thus, these results suggested that
differentiation of CD4 T cells into CD8aa T cells occurred at
the site of immune reactions and that newly generated CD8aa T
cells migrated into the gut through the expression of gut-homing
receptors, as previously indicated26,36. In a previous study, we
found that Runx32/2 mice showed defects in recovery from colitis
and thereby increased the formation of inflammation-associated
tumors40. We speculated that differentiated CD8aa T cells
attenuate immune reactions and decrease the harmful effects of
continuous inflammation, given that CD8aa Tregs are known to
suppress activated T cells specifically. For a more detailed assess-
ment of this hypothesis, we used mice with EAE as a model
system. In this model, CD8 T cells play a key role in reducing the
frequency of relapse after recovery from acute EAE41,42. This
autoimmune disease is accordingly a suitable model for assessing
the regulatory functions of CD8 Tregs. As expected, no differences
in onset, clinical scores in the early phase, or EAE incidence were
observed between genotypes. However, Runx32/2 mice exhibited
defects in recovery from EAE, as indicated by the increased clinical
scores after 6 weeks (P 5 0.0010; Fig. 7A). To exclude effects derived
from other lineage cells, we performed EAE-induction experiments
using Rag22/2 mice, having transferred CD4 T cells from Runx32/2
and wild-type mice. Again, Rag22/2 mice having Runx32/2 CD4 T
cells showed defects in recovery from EAE (P 5 0.0048; Fig. 7B).
These results indicate that Runx3 functions in CD4 T cells are
important for recovery from EAE. Various CD4-derived cells are
involved in EAE regulation: Th17, Th1, and CD41Foxp31 Treg
cells. Th17 and Th1 are important for the induction of EAE
disease. However, Runx family transcription factors are positive
regulators for Th1 and Th17 differentiation, indicating that Runx3
deficiency will contribute to inhibiting EAE disease. Furthermore,
Treg cell differentiation and function are not strongly affected by
Runx3 deficiency, as shown previously40,48. In sum, the defect in
recovery from EAE disease observed in Rag22/2 mice having
Runx3-deficient CD4 T cells cannot be explained by previously
known functions of Runx3 in CD4 T cells. For these reasons, we
concluded that CD4-derived CD8aa T cells function as immune
regulatory cells, at least in this EAE model. These observations
support the hypothesis that differentiated CD8aa T cells play an
important regulatory role in the establishment of a negative
feedback loop that decreases adverse effects during immune
reactions.
Figure 6 | CD4 T cells differentiate into CD8aa Tregs during immune responses. (A) Naı¨ve CD41 T cells (CD45.2) were injected into Rag22/2mice.
TCRab1CD45.21 cells from spleen at 1, 3 and 6 days after immunization were analysed for expression of CD8a and CD4. (B) FACS analysis of
lymphocytes from tissues of mice used for (A). TCRab1CD45.21 cells were examined for expression of CD4 and CD8a. CD4-CD8a1 T cells were
further examined for expression of CD8a and CD8b. All experiments were performed at least three times, and representative data are shown.
www.nature.com/scientificreports
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This study revealed previously unknown CD8 T-cell subsets that
were derived from activated peripheral CD4 T cells (Fig. 8) and a
unique mechanism for generating activated CD8 T cells without
other CD4T cells. Furthermore, these T-cell subsets can likely inhibit
immune reactions. The elucidation of the precisemechanism of these
processes and the exact functions of these cell subsets will provide
fundamental insights for future autoimmune disease therapies.
Discussion
CD4 T cells are known to differentiate into various helper and reg-
ulatory T-cell lineages, namely Th1, Th2, Th9, Th17, TFH, and
CD41Foxp31 Tregs. In addition to these subsets, we identified a
new cell population in this study called CD8aa Tregs, which have a
regulatory function. Differentiation of CD8aa Tregs required the
same signals as iTregs. However, the differentiation of CD8aa
Tregs took more time than that of iTregs, and stronger TCR stimu-
lation and higher atRA concentrations were required for their gen-
eration. These data indicate that the determination of the cell fate
of one of the two inducible Treg cell subsets was differentially con-
trolled during immune reactions. Therefore, iTregs and CD8aa
Tregs may have distinct functions in immune regulation. Ac-
cording to this concept, someCD8aaT-cell subsets have been shown
to have the property of inhibiting activated, but not naı¨ve, T cells. Qa-
1 in mouse (or HLA-E in human), which is a nonclassical MHC class
I molecule, has been believed to play a key role in restricting the
activity of CD8aa Tregs only toward activated T cells because these
molecules are transiently upregulated on the surface of activated T
cells and antigen-presenting cells. The correlation between CD8
Tregs and Qa-1 was suggested on the basis of previous studies as
follows. Immunization with Qa-1-expressing activated CD4 T cells
induces Qa-1-restricted CD8 Tregs43,44; CD8aa Treg clones recog-
nize a TCR-derived peptide presented on Qa-111; Qa-12/2mice show
augmentation of CD4T-cell responses and increased susceptibility to
EAE45; resistance to the re-induction of EAE was lost in CD8- and
Qa-1-deficient mice41,42,45,46. In this study, we observed defects in
recovery from EAE in Runx3-deficient mice in which CD4 T cells
could not differentiate into CD8aa Tregs. These data indicate that
CD8aa Tregs play a special role in the regulation of activated T cells.
However, the molecular mechanisms underlying the suppressor
functions of CD8aa Tregs are poorly understood. Furthermore,
the exact target cells of CD8aa T cells and the relationship between
CD8aa Tregs and Qa-1 in various immune reactions remain to be
studied47.
We found striking similarities between signals for CD4 and
CD8aa Tregs. In addition, differentiation of these two regulatory
T-cell subsets requires Runx protein activities; CD8aa Tregs require
Runx3 and CD4 Tregs require Runx148. Whether the different func-
tions of Runx1 and Runx3 or the total amount of Runx proteins
influence the determination of cell fate remains to be clarified.
CD8aaT cells aremajor populations of IELs, andmost of them are
selected in the thymus. The commitment of CD8aaTCRab T cells
occurs from both MHC class I- and class II-restricted T cells16,17.
Moreover, CD8aa IELs are absent in b2-microglobulin-deficient
mice but not in MHC class Ia-deficient mice49,50. From these obser-
vations, MHC class Ib molecules, including Qa-1, are believed to be
required for the selection of CD8aa T cells. In this study, we showed
that CD4 T cells differentiated into CD8aa T cells in the periphery,
indicating that MHC class II-dependent primary selection of these
cells occurred in the thymus. It is of interest to determine the exact
roles of the Qa-1 molecule in the differentiation, maintenance, or
expansion of CD4-derived CD8aa T cells.
In summary, we have identified a new subset of inducible Treg
cells (Fig. 8). This differentiation system can be affected by various
immune dysfunctions, including autoimmune diseases and tumor
immunity. We anticipate that further elucidation of the precise
mechanisms of this process will provide a basis for development of
anti-cancer drugs and a rationale for treatment of autoimmunity.
Methods
Mice. This study received appropriate ethics approval from the Institutional Review
Board of Kyoto University (Reference Number: Med Kyo12076). Wild-type (WT),
Runx31/2, Runx21/2 and Rag22/2 mice (CD45.1) in a C57BL/6 genetic background
were maintained in a specific pathogen-free mouse facility. Procedures involving
Figure 7 | Runx32/2 T cells cause defect in recovery from EAE. Rag22/2 mice with (A) WT or Runx32/2 lymphocytes and (B) WT or Runx32/2 CD4 T
cells were followed up for signs of neurological disease after experimental autoimmune encephalomyelitis (EAE) induction. Data shown are mean 6
standard error of mean of EAE clinical score of 10 mice pooled from two independent experiments and percentage disease incidence.
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animals and their care were in accordance with the guidelines for animal treatment of
the Institute of Laboratory Animals, Kyoto University.
Fetal liver transfer. Single-cell suspensions of 2–4 3 106 whole fetal liver
mononuclear cells harvested from Runx32/2, Runx22/2Runx32/2and WT (CD45.2)
embryos at E14.5 were injected intravenously into sublethally irradiated (4 Gy)
Rag22/2 recipient mice (CD45.1). At least 10 weeks after transplantation, mice were
used for EAE induction or were killed, and their naı¨ve CD4 T cells were analyzed by
flow cytometry or used for in vitro culture. In some experiments, naı¨ve CD4 T cells
were purified and adoptively transferred into other Rag22/2 recipient mice (CD45.1).
All Rag22/2 (CD45.1) mice used for each experimental set were age- and
sex-matched.
Cell preparation. Naı¨ve CD41TCRab1 was prepared by magnetic cell sorting
(MACS) using a CD41 CD62L1 T cell isolation kit (Miltenyi Biotec, Bergisch,
Germany) in combination with various antibodies (BD Pharmingen). Briefly, lineage
positive cells, but not CD4, were removed according to themanufacturer’s instruction
using biotin-conjugated lineage-specific antibodies and a-Biotin microbeads. After
negative selection, we made a rough prediction of the final concentration of
contaminated CD4-CD62L1 cells after purification of CD41CD62L1 cells. For this
purpose, a part of the negatively selected cells were stained with a-CD4 and a-CD62L
antibodies. If more than 5% cells were CD4-CD62L1 among CD62L1 cells, we
performed negative selection again using the following antibodies and magnetic
beads; a-CD8a-FITC, a-CD25-Biotin, a-CD19-Biotin, a-B220-Biotin, a-CD11b-
Biotin, a-CD11c-Biotin, a-Ia-Biotin, a-Dx5-Biotin, a-TCRcd-Biotin, Ter119-Biotin
(Becton Dickinson, Mountain View, CA), a-FITC microbeads and streptavidin
microbeads (Myltenyi Biotech Bergisch, Germany). After the second round of
negative selection was finished, CD62L1 cells were further selected according to
the manufacturer’s instructions. Purities were determined by staining with
antibodies for CD8a, CD8b, CD4 and CD62L. Usually, more than 97% cells were
CD41CD62L1 and fewer than 0. 02% cells were CD8a1. CD8aa cells cannot be
detected. If more than 0.02% cells were positive for CD8a expression or fewer
than 97% cells were CD41CD62L1, we further purified CD41CD62L1 cells by
flow cytometry using FACSAria. All the purified cells using the above method
were used for both in vitro culture and cell transfer experiments into RAG22/2
mice. Essentially all the methods of purification were used for in vitro culture and
cell-transfer experiments.
For purification of CD4 T cells, spleen cells were subjected to negative selection
using the following antibodies and magnetic beads; a-CD8a-FITC, a-CD19-Biotin,
a-B220-Biotin, a-CD11b-Biotin, a-CD11c-Biotin, a-Ia-Biotin, a-Dx5-Biotin,
a-TCRcd-Biotin, Ter119-Biotin (Becton Dickinson), a-FITC microbeads and
streptavidin microbeads.
CD8ab1TCRab1 T cells was prepared by MACS using a CD8a1 T cell isolation
kit (Miltenyi Biotec) in combination with various antibodies (BD Pharmingen).
Briefly, lineage positive cells, but not CD8, were removed according to the manu-
facturer’s instruction using biotin-conjugated lineage-specific antibodies and
a-Biotin microbeads. Then we further performed second round of negative selection
using the following antibodies and magnetic beads; a-CD4-Biotin, a-CD19-Biotin,
a-B220-Biotin, a-CD11b-Biotin, a-CD11c-Biotin, a-Ia-Biotin, a-Dx5-Biotin,
a-TCRcd-Biotin, Ter119-Biotin (Becton Dickinson), and Streptavidin microbeads.
After a second round of negative selection, CD8b cells were positively selected by
MACS. Usually more than 98% of populations were CD8ab1 cells and fewer than
0.5 % were CD8aa1 cells. If fewer than 96% cells were CD8ab1, or more than
1.0%were CD8 aa1 cells, we further purified CD8ab1 cells by flow cytometry using
FACSAria. All the purified cells using above method were used for both in vitro
culture or cell transfer experiments into RAG22/2 mice.
Transfer of CD4 T cells or naı¨ve CD4 T cells. Naı¨ve CD4 T cells were prepared as
described above; 0.5–2.5 3 106 naı¨ve CD4 T cells (CD45.2) were transferred into
Rag22/2 (CD45.1) mice. At least 4 weeks after transplantation, the mice were used for
various experiments. For EAE experiments, 2.5 x106 CD4 T cells (CD45.2) were
transferred into Rag22/2 (CD45.1)mice. Several days after transplantation, mice were
used for EAE induction.
Cell cultures. In all experiments, the percentages of CD62L1CD41 T cells or
CD8ab1 T cells were above 97. Naı¨ve CD41 T cells (1 3 105 cells /mL) were
activated with plate-bound anti-CD3 (5 mg/mL; BD Pharmingen), soluble anti-CD28
(1 mg/mL; BD Pharmingen), anti-interferon-c (3 mg/mL; BD Pharmingen), anti-IL-4
(3 mg/mL; BD Pharmingen), TGF-b1 (3 ng/mL; R&D) and IL-2 (20 ng/mL; R&D) in
the presence or absence of atRA (10 nM–10 mM; Sigma-Aldrich) for 7–9 days.
RA injection. atRA (Sigma-Aldrich, Saint Louis, MO) was dissolved in soybean oil at
6 mg/mL and aliquots were stored at 280uC. A working solution was prepared by
diluting the atRA aliquots in soybean oil and an equal volume of dimethyl sulfoxide
Figure 8 | Schematic of CD8aa T cell differentiation pathways.
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(DMSO). atRA of 200 mg/100 mL, 600 mg/300 mL or vehicle was delivered by
intraperitoneal injection 1, 3, and 6 d before analysis.
Flow cytometric analysis. The following antibodies were used for staining: PECy7
anti-CD45.2 (BD Pharmingen); allophycocyanin (APC) anti-mouse TCRab (BD
Pharmingen); APCCy7 anti-mouse CD8a (BD Pharmingen); fluorescein
isothiocyanate (FITC) anti-mouse CD8b (BDPharmingen); phycoerythrin (PE) anti-
mouse CD4 (BD Pharmingen); PE anti-mouse CD8a (BD Pharmingen); APC anti-
mouse CD4 (BD Pharmingen); FITC anti-mouse CD8a (BD Pharmingen); FITC
anti-mouse CD4 (BD Pharmingen); PE anti-mouse CD44 (BD Pharmingen); Biotin
anti-mouse CD122 (BD Pharmingen); APC anti-mouse CXCR5 (BD Pharmingen);
Biotin anti-mouse a4b7 (BD Pharmingen); FITC anti-mouse CCR9 (R&D); PE anti-
mouse Granzyme A (Santa Cruz CA); Alexa 647 anti-Foxp3 (BD Pharmingen); Alexa
647 anti-Granzyme B (BD Pharmingen); PerCP–streptavidin (Molecular Probes,
Eugene, OR); APC–streptavidin (Molecular Probes, Eugene, OR); APCCy7–
streptavidin (BD Pharmingen); PECy7–streptavidin (BD Pharmingen);
PE–streptavidin (Molecular Probes); FITC–streptavidin (Molecular Probes).
For cytoplasmic staining, BD Cytofix/Cytoperm solution and BD Perm/Wash
solutions (BD Pharmingen) were used.
All analyses were performed with FACSCalibur or FACSAria (Becton Dickinson).
IELs and LPLs preparation. To prepare IELs and LPLs, the intestines were removed,
and PPs and mononuclear lymphocytes were isolated. The intestines were opened
longitudinally, washed with phosphate-buffered saline, and cut into 5-mm pieces. To
obtain IELs, pieces were shaken in Hank’s balanced salt solution (1) containing
5 mM ethylenediaminetetraacetic acid for 20 min at 37uC and passed through a cell
strainer twice. The remaining tissue was cut into smaller pieces and digested with
RPMI 1640 medium containing 4% fetal calf serum, 1 mg/mL collagenase II,
1 mg/mL Dispase (Gibco), and 40 mg/ml DNase I (TaKaRa) at 37uC and stirred for
20 min. Whole intestinal cell suspensions, which included LPL or IEL, were passed
through a cell strainer and loaded on a 40/80% discontinuous Percoll gradient (GE
Healthcare), and cells at the interface between 40% and 80% were collected and used
as IELs or LPLs.
Immunization. 100 mg NP- chicken gamma globulin (CGG) in alum or complete
Freund’s adjuvant (incomplete Freund’s adjuvant with Mycobacterium tuberculosis
H37RA; Difco) was intraperitoneally injected.
EAE induction and clinical scoring. Age- and sex-matched mice were immunized
subcutaneously with 100 mg MOG35-55 (Genway, China) in IFA (incomplete
Freund’s adjuvant) supplemented with 500 mgMycobacterium tuberculosis on day 1.
On days 1 and 3, mice were injected with 300 ng pertussis toxin (List Biological
Laboratories). Clinical signs were scored on a scale of 1–5: 0, no clinical sign; 0.5,
partially limp tail; 1, paralyzed tail; 2, loss of coordinated movement, hind limb
paresis; 2.5, one hind limb paralyzed; 3, both hind limbs paralyzed, 3.5, hind limbs
paralyzed, weakness in fore limbs; 4, fore limbs paralyzed; and 5, moribund.
Reverse transcription polymerase chain reaction (RT-PCR). Total RNAs were
extracted from sorted T cells using TRIzol reagent (Gibco-BRL, Gaithersburg, MD).
Oligo (dT)-primed cDNAs were prepared by reverse transcription. For
semiquantitation, 50 ng cDNA was serially diluted and subjected to PCR. All PCR
products were resolved electrophoretically on 2% agarose gels and visualized by
ethidium bromide staining.
Statistical analysis. Proportions of cells were compared with Student’s t test
(Fig. 1A). To see the effect of Runx3 in EAE recovery, the mean clinical scores
were compared between genotypes using repeated measures analysis of variance
(ANOVA). Greenhouse–Geiser correction was applied to adjust the degree of
freedom for deviation from the sphericity assumption (Fig. 7A). All reported P
values were two-tailed and P values lower than 0.05 were considered to indicate
statistical significance.
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